Protection against the oxidation of composite material parts containing carbon and parts thus protected

Details for Australian Patent Application No. 2004260914 (hide)

Owner Snecma Propulsion Solide

Inventors Thebault, Jacques; Diss, Pascal

Agent FB Rice

Pub. Number AU-B-2004260914

PCT Pub. Number WO2005/012744

Priority 03/09424 31.07.03 FR

Filing date 29 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 12 November 2009

International Classifications

C04B 41/50 (2006.01) After-treatment of mortars, concrete, artificial stone or ceramics

C04B 41/52 (2006.01) After-treatment of mortars, concrete, artificial stone or ceramics

C04B 41/85 (2006.01) After-treatment of mortars, concrete, artificial stone or ceramics - with inorganic materials

C04B 41/89 (2006.01) After-treatment of mortars, concrete, artificial stone or ceramics - for obtaining at least two superposed coatings having different compositions

F16D 69/02 (2006.01) Friction linings - Composition of linings

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012744 Priority application(s): WO2005/012744

12 November 2009 Application Accepted

  Published as AU-B-2004260914

11 March 2010 Standard Patent Sealed

19 January 2012 Licence Registered

  Snecma Propulsion Solide ( Messier-Bugatti )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260921-Process for the manufacture of a bitumen-aggregate mix suitable for road pavement

2004260895-Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation